全文获取类型
收费全文 | 159513篇 |
免费 | 2513篇 |
国内免费 | 129篇 |
专业分类
耳鼻咽喉 | 4687篇 |
儿科学 | 5148篇 |
妇产科学 | 6256篇 |
基础医学 | 28451篇 |
口腔科学 | 3738篇 |
临床医学 | 7984篇 |
内科学 | 33717篇 |
皮肤病学 | 6650篇 |
神经病学 | 11284篇 |
特种医学 | 6575篇 |
外科学 | 24942篇 |
综合类 | 707篇 |
一般理论 | 12篇 |
预防医学 | 6230篇 |
眼科学 | 5967篇 |
药学 | 5862篇 |
中国医学 | 154篇 |
肿瘤学 | 3791篇 |
出版年
2015年 | 3799篇 |
2014年 | 4583篇 |
2013年 | 6061篇 |
2012年 | 5194篇 |
2011年 | 5011篇 |
2010年 | 4735篇 |
2009年 | 4715篇 |
2008年 | 5061篇 |
2007年 | 5009篇 |
2006年 | 5436篇 |
2005年 | 4858篇 |
2004年 | 4436篇 |
2003年 | 2773篇 |
2002年 | 1463篇 |
1999年 | 1135篇 |
1998年 | 1393篇 |
1997年 | 1375篇 |
1996年 | 1770篇 |
1995年 | 1901篇 |
1994年 | 1927篇 |
1993年 | 1804篇 |
1992年 | 1927篇 |
1991年 | 1685篇 |
1990年 | 1512篇 |
1989年 | 1358篇 |
1988年 | 1266篇 |
1987年 | 1324篇 |
1986年 | 1252篇 |
1985年 | 1086篇 |
1984年 | 1218篇 |
1983年 | 1006篇 |
1982年 | 1232篇 |
1981年 | 1141篇 |
1980年 | 1072篇 |
1979年 | 1085篇 |
1978年 | 1227篇 |
1977年 | 971篇 |
1973年 | 973篇 |
1933年 | 1513篇 |
1932年 | 1495篇 |
1931年 | 1484篇 |
1930年 | 1670篇 |
1929年 | 1397篇 |
1928年 | 1535篇 |
1927年 | 1508篇 |
1926年 | 1591篇 |
1925年 | 1550篇 |
1924年 | 1615篇 |
1923年 | 1473篇 |
1922年 | 1444篇 |
排序方式: 共有10000条查询结果,搜索用时 313 毫秒
11.
12.
13.
Lorena Martin-Morales Sara Manzano Maria Rodrigo-Faus Adrian Vicente-Barrueco Victor Lorca Gonzalo Núñez-Moreno Paloma Bragado Almudena Porras Trinidad Caldes Pilar Garre Alvaro Gutierrez-Uzquiza 《International journal of cancer. Journal international du cancer》2023,152(2):283-297
Matrix metalloproteinase-11 (MMP11) is an enzyme with proteolytic activity against matrix and nonmatrix proteins. Although most MMPs are secreted as inactive proenzymes and are later activated extracellularly, MMP11 is activated intracellularly by furin within the constitutive secretory pathway. It is a key factor in physiological tissue remodeling and its alteration may play an important role in the progression of epithelial malignancies and other diseases. TCGA colon and colorectal adenocarcinoma data showed that upregulation of MMP11 expression correlates with tumorigenesis and malignancy. Here, we provide evidence that a germline variant in the MMP11 gene (NM_005940: c.232C>T; p.(Pro78Ser)), identified by whole exome sequencing, can increase the tumorigenic properties of colorectal cancer (CRC) cells. P78S is located in the prodomain region, which is responsible for blocking MMP11's protease activity. This variant was detected in the proband and all the cancer-affected family members analyzed, while it was not detected in healthy relatives. In silico analyses predict that P78S could have an impact on the activation of the enzyme. Furthermore, our in vitro analyses show that the expression of P78S in HCT116 cells increases tumor cell invasion and proliferation. In summary, our results show that this variant could modify the structure of the MMP11 prodomain, producing a premature or uncontrolled activation of the enzyme that may contribute to an early CRC onset in these patients. The study of this gene in other CRC cases will provide further information about its role in CRC development, which might improve patient treatment in the future. 相似文献
14.
Alexander Real Chierika Ukogu Divya Krishnamoorthy Nicole Zubizarreta Samuel K. Cho Andrew C. Hecht James C. Iatridis 《The spine journal》2019,19(2):225-231
Background Context
Low back pain (LBP) is a common complaint in clinical practice of multifactorial origin. Although obesity has been thought to contribute to LBP primarily by altering the distribution of mechanical loads on the spine, the additional contribution of obesity-related conditions such as diabetes mellitus (DM) to LBP has not been thoroughly examined.Purpose
To determine if there is a relationship between DM and LBP that is independent of body mass index (BMI) in a large cohort of adult survey participants.Study Design
Retrospective analysis of prospectively collected National Health and Nutrition Examination Survey (NHANES) data to characterize associations between LBP, DM, and BMI in adults subdivided into 6 subpopulations: normal weight (BMI 18.5–25), overweight (BMI 25–30), and obese (BMI >30) diabetics and nondiabetics. Diabetes was defined with glycohemoglobin A1c (HbA1c) ≥6.5%.Patient Sample
11,756 participants from NHANES cohort.Outcome Measures
Percentage of LBP reported.Methods
LBP reported in the 1999-2004 miscellaneous pain NHANES questionnaire was the dependent variable examined. Covariates included HbA1c, BMI, age, and family income ratio to poverty as continuous variables as well as race, gender, and smoking as binary variables. Individuals were further subdivided by weight class and diabetes status. Regression and graphical analyses were performed on the study population as a whole and also on subpopulations.Results
Increasing HbA1c did not increase the odds of reporting LBP in the full cohort. However, multivariate logistic regression of the 6 subpopulations revealed that the odds of LBP significantly increased with increasing HbA1c levels in normal weight diabetics. No other subpopulations reported significant relationships between LBP and HbA1c. LBP was also significantly associated with BMI for normal weight diabetics and also for obese subjects regardless of their DM status.Conclusions
LBP is significantly related to DM status, but this relationship is complex and may interact with BMI. These results support the concept that LBP may be improved in normal weight diabetic subjects with improved glycemic control and weight loss, and that all obese LBP subjects may benefit from improved weight loss alone. 相似文献15.
16.
Alexander C. Egbe Rosalyn Adigun Vidhu Anand Collin P. West Victor M. Montori Hassan M. Murad Emmanuel Akintoye Karim Osman Heidi M. Connolly 《The Canadian journal of cardiology》2019,35(12):1784-1790
BackgroundAlthough there are robust data about the pathophysiology and prognostic implications of left ventricular (LV) systolic dysfunction in patients with acquired heart disease, similar prognostic data about LV systolic dysfunction are sparse in the tetralogy of Fallot (TOF) population. The purpose of this study was to perform a meta-analysis of all studies that assessed the relationship between LV ejection fraction (LVEF) and cardiovascular adverse events (CAEs) defined as death, aborted sudden death, or sustained ventricular tachycardia.MethodsWe used random-effects models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).ResultsOf the 1,809 citations, 7 studies with 2,854 patients (age 28 ± 4 years) were included. During 5.6 ± 3.4 years' follow-up, there were 82 deaths, 17 aborted sudden cardiac deaths, and 56 sustained ventricular tachycardia events. Overall, CAEs occurred in 5.1% (144 patients). As a continuous variable, LVEF was a predictor of CAE (HR 1.29, 95% CI, 1.09-1.53, P = 0.001) per 5% decrease in LVEF. Similarly, LVEF < 40% was also a predictor of CAE (HR 3.22, 95% CI, 2.16-4.80, P < 0.001).ConclusionsLV systolic dysfunction was an independent predictor of CAE, and we observed a 30% increase in the risk of CAE for every 5% decrease in LVEF, and a 3-fold increase in the risk of CAE in patients with LVEF <40% compared with other patients. These findings underscore the importance of incorporating LV systolic function in clinical risk stratification of patients with TOF and the need to explore new treatment options to address this problem. 相似文献
17.
18.
19.
20.